Similarly, peripheral administration of exendin4 suppressed food intake and body weight equally in rats that underwent lesioning of the chemoreceptor trigger zone (CTS) for emesis the area postrema (Baraboi et al., 2010)
Of interest, the mechanisms of action of these two classes of drugs are different and potentially complementary, supporting the combined use of GLP-1RAs and SGLT2i in people with type 2 diabetes [84,85,86,87,88,89]
FDA-approved GLP-1 medications are typically designed for once-weekly use unless otherwise specified
We are now able to seamlessly support those interested in exploring if clinical interventions are right for them with WeightWatchers Clinic, as well as ensure they have a holistic resource for adopting healthy habits while adjusting to, and managing life on medications, with the WeightWatchers GLP-1 Program, said Sima Sistani, Chief Executive Officer, WeightWatchers